Clot Burden Score and Collateral Status and Their Impact on Functional Outcome in Acute Ischemic Stroke.


Journal

AJNR. American journal of neuroradiology
ISSN: 1936-959X
Titre abrégé: AJNR Am J Neuroradiol
Pays: United States
ID NLM: 8003708

Informations de publication

Date de publication:
01 2021
Historique:
received: 12 05 2020
accepted: 12 08 2020
pubmed: 14 11 2020
medline: 23 3 2021
entrez: 13 11 2020
Statut: ppublish

Résumé

Collateral status and thrombus length have been independently associated with functional outcome in patients with acute ischemic stroke. It has been suggested that thrombus length would influence functional outcome via interaction with the collateral circulation. We investigated the individual and combined effects of thrombus length assessed by the clot burden score and collateral status assessed by a FLAIR vascular hyperintensity-ASPECTS rating system on functional outcome (mRS). Patients with anterior circulation acute ischemic stroke due to large-vessel occlusion from the ASTER and THRACE trials treated with endovascular thrombectomy were pooled. The clot burden score and FLAIR vascular hyperintensity score were determined on MR imaging obtained before endovascular thrombectomy. Favorable outcome was defined as an mRS score of 0-2 at 90 days. Association of the clot burden score and the FLAIR vascular hyperintensity score with favorable outcome (individual effect and interaction) was examined using logistic regression models. Of the 326 patients treated by endovascular thrombectomy with both the clot burden score and FLAIR vascular hyperintensity assessment, favorable outcome was observed in 165 (51%). The rate of favorable outcome increased with clot burden score (smaller clots) and FLAIR vascular hyperintensity (better collaterals) values. The association between clot burden score and functional outcome was significantly modified by the FLAIR vascular hyperintensity score, and this association was stronger in patients with good collaterals, with an adjusted OR = 6.15 (95% CI, 1.03-36.81). The association between the clot burden score and functional outcome varied for different collateral scores. The FLAIR vascular hyperintensity score might be a valuable prognostic factor, especially when contrast-based vascular imaging is not available.

Sections du résumé

BACKGROUND AND PURPOSE
Collateral status and thrombus length have been independently associated with functional outcome in patients with acute ischemic stroke. It has been suggested that thrombus length would influence functional outcome via interaction with the collateral circulation. We investigated the individual and combined effects of thrombus length assessed by the clot burden score and collateral status assessed by a FLAIR vascular hyperintensity-ASPECTS rating system on functional outcome (mRS).
MATERIALS AND METHODS
Patients with anterior circulation acute ischemic stroke due to large-vessel occlusion from the ASTER and THRACE trials treated with endovascular thrombectomy were pooled. The clot burden score and FLAIR vascular hyperintensity score were determined on MR imaging obtained before endovascular thrombectomy. Favorable outcome was defined as an mRS score of 0-2 at 90 days. Association of the clot burden score and the FLAIR vascular hyperintensity score with favorable outcome (individual effect and interaction) was examined using logistic regression models.
RESULTS
Of the 326 patients treated by endovascular thrombectomy with both the clot burden score and FLAIR vascular hyperintensity assessment, favorable outcome was observed in 165 (51%). The rate of favorable outcome increased with clot burden score (smaller clots) and FLAIR vascular hyperintensity (better collaterals) values. The association between clot burden score and functional outcome was significantly modified by the FLAIR vascular hyperintensity score, and this association was stronger in patients with good collaterals, with an adjusted OR = 6.15 (95% CI, 1.03-36.81).
CONCLUSIONS
The association between the clot burden score and functional outcome varied for different collateral scores. The FLAIR vascular hyperintensity score might be a valuable prognostic factor, especially when contrast-based vascular imaging is not available.

Identifiants

pubmed: 33184069
pii: ajnr.A6865
doi: 10.3174/ajnr.A6865
pmc: PMC7814780
doi:

Banques de données

ClinicalTrials.gov
['NCT02523261', 'NCT01062698']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

42-48

Informations de copyright

© 2021 by American Journal of Neuroradiology.

Références

J Stroke. 2017 Jan;19(1):40-49
pubmed: 28178411
AJNR Am J Neuroradiol. 2009 Mar;30(3):525-31
pubmed: 19147716
Stroke. 2016 Dec;47(12):2972-2978
pubmed: 27827328
J Stroke. 2018 Sep;20(3):416
pubmed: 29961304
Lancet Neurol. 2011 Oct;10(10):909-21
pubmed: 21939900
AJNR Am J Neuroradiol. 2015 Feb;36(2):269-74
pubmed: 25190202
Stroke. 2017 Jul;48(7):1895-1900
pubmed: 28596447
Stroke. 2019 Aug;50(8):2057-2064
pubmed: 31216961
Stroke. 2019 Mar;50(3):659-664
pubmed: 30744542
Stroke. 2007 Dec;38(12):3205-12
pubmed: 17975102
J Cereb Blood Flow Metab. 2017 Nov;37(11):3589-3598
pubmed: 27864462
Stroke. 2016 Feb;47(2):424-7
pubmed: 26732567
Stroke. 2014 Jul;45(7):2010-7
pubmed: 24916912
Int J Stroke. 2008 Nov;3(4):230-6
pubmed: 18811738
Stroke. 2019 Oct;50(10):2799-2804
pubmed: 31426729
AJNR Am J Neuroradiol. 2012 Mar;33(3):576-82
pubmed: 22135128
JAMA. 2017 Aug 1;318(5):443-452
pubmed: 28763550
Lancet Neurol. 2018 Oct;17(10):895-904
pubmed: 30264728
Stroke. 2013 Jul;44(7):1878-84
pubmed: 23704103
Radiology. 2015 Mar;274(3):851-8
pubmed: 25559232
Lancet Neurol. 2016 Oct;15(11):1138-47
pubmed: 27567239
Stroke. 2015 Jun;46(6):1453-61
pubmed: 25944319
Stroke. 2007 Mar;38(3):967-73
pubmed: 17272772
J Stroke. 2019 Jan;21(1):91-100
pubmed: 30732444
Stroke. 2018 Mar;49(3):675-681
pubmed: 29459394
Stroke. 2016 Nov;47(11):2763-2769
pubmed: 27659851
Stroke. 2016 Mar;47(3):768-76
pubmed: 26903582
Stroke. 2019 Apr;50(4):867-872
pubmed: 30908160
Lancet. 2016 Apr 23;387(10029):1723-31
pubmed: 26898852
Neuroradiology. 2015 Jan;57(1):1-9
pubmed: 25287075
AJNR Am J Neuroradiol. 2013 Oct;34(10):1908-13
pubmed: 23620073
Radiology. 2000 May;215(2):476-82
pubmed: 10796928
Can J Neurol Sci. 2015 Nov;42(6):381-8
pubmed: 26365832
Stroke. 2013 Sep;44(9):2650-63
pubmed: 23920012
Stroke. 2017 Sep;48(9):2621-2627
pubmed: 28794271
J Neuroimaging. 2017 Nov;27(6):577-582
pubmed: 28771893
Psychol Bull. 1992 Jul;112(1):155-9
pubmed: 19565683
Stroke. 2018 Feb;49(2):391-396
pubmed: 29321337

Auteurs

I Derraz (I)

From the Department of Neuroradiology (I.D.), Hôpital Gui de Chauliac, Montpellier University Medical Center, Montpellier, France i-derraz@chu-montpellier.fr.

M Pou (M)

Department of Neuroradiology (M.P., F.C.).

J Labreuche (J)

Santé publique: épidémiologie et qualité des soins (J.L.), University of Lille, Centre Hospitalier Universitaire Lille, Lille, France.

L Legrand (L)

Department of Neuroradiology (L.L., G.B., C.O., O.N.), Groupe Hospitalier Universitaire site Sainte-Anne, Institut de Psychiatrie et Neurosciences de Paris, National Institute for Health and Medical Research, Université de Paris, Paris, France.

S Soize (S)

Department of Neuroradiology (S.S.), Centre Hospitalier Universitaire Reims, Reims, France.

M Tisserand (M)

Department of Neuroradiology (M.T.).

C Rosso (C)

Institut du Cerveau et de la Moelle épinière (C.R.), Sorbonne Université, Institut du Cerveau, National Institute for Health and Medical Research U 1127, Urgences Cérébro-Vasculaires, Hôpital Pitié-Salpêtrière, Paris, France.

M Piotin (M)

Department of Interventional Neuroradiology (M.P.), Rothschild Fondation, Paris, France.

G Boulouis (G)

Department of Neuroradiology (L.L., G.B., C.O., O.N.), Groupe Hospitalier Universitaire site Sainte-Anne, Institut de Psychiatrie et Neurosciences de Paris, National Institute for Health and Medical Research, Université de Paris, Paris, France.

C Oppenheim (C)

Department of Neuroradiology (L.L., G.B., C.O., O.N.), Groupe Hospitalier Universitaire site Sainte-Anne, Institut de Psychiatrie et Neurosciences de Paris, National Institute for Health and Medical Research, Université de Paris, Paris, France.

O Naggara (O)

Department of Neuroradiology (L.L., G.B., C.O., O.N.), Groupe Hospitalier Universitaire site Sainte-Anne, Institut de Psychiatrie et Neurosciences de Paris, National Institute for Health and Medical Research, Université de Paris, Paris, France.

S Bracard (S)

Department of Neuroradiology (S.B.), Regional and University Hospital Centre Nancy, Nancy, France.

F Clarençon (F)

Department of Neuroradiology (M.P., F.C.).

B Lapergue (B)

Stroke Center (B.L.), Foch Hospital, Suresnes, France.

R Bourcier (R)

Department of Diagnostic and Interventional Neuroradiology (R.B.), Guillaume et René Laennec University Hospital, Nantes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH